Gene: LRP11
Official Full Name: LDL receptor related protein 11provided by HGNC
Gene Summary: Enables phosphoprotein binding activity. Predicted to be involved in several processes, including response to cold; response to immobilization stress; and response to water deprivation. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03414 | LRP11 Knockout cell line (HeLa) | Human | LRP11 | 1:3~1:6 | Negative | Online Inquiry |
KO03415 | LRP11 Knockout cell line (HCT 116) | Human | LRP11 | 1:2~1:4 | Negative | Online Inquiry |
KO03416 | LRP11 Knockout cell line (HEK293) | Human | LRP11 | 1:3~1:6 | Negative | Online Inquiry |
KO03417 | LRP11 Knockout cell line (A549) | Human | LRP11 | 1:3~1:4 | Negative | Online Inquiry |
LRP11 Gene Knockout Cell Lines are specialized cellular models engineered to specifically lack the expression of the LRP11 (Low-Density Lipoprotein Receptor-Related Protein 11) gene. These cell lines are invaluable tools for researchers seeking to elucidate the functional roles of LRP11 in various biological processes, including lipid metabolism, cellular signaling, and potential implications in disease mechanisms such as cancer and metabolic disorders. By knocking out LRP11, researchers can analyze the resultant phenotypic changes and molecular pathways that may be influenced by this receptor, offering insights into its contributions to cellular physiology.
The mechanism underlying our LRP11 Gene Knockout Cell Lines involves targeted gene editing techniques, such as CRISPR-Cas9 technology, enabling precise removal of the LRP11 gene. This innovative approach facilitates the study of gene function in a controlled environment, allowing for a clearer understanding of how LRP11 may interact with other proteins and pathways.
In scientific research and clinical applications, these cell lines hold significant importance. They provide a platform for drug screening and the development of therapeutic strategies aimed at targeting LRP11-associated pathways. Furthermore, they can be employed in metabolic studies to explore how the absence of LRP11 influences lipid accumulation and cellular health.
What sets our LRP11 Gene Knockout Cell Lines apart from alternatives is the precision of our gene editing technology and the reliability of our validation processes, ensuring reproducibility and accuracy in results. This makes them exceptionally valuable for researchers looking to obtain consistent and trustworthy data that can enhance their understanding of LRP11’s role in health and disease.
Investing in LRP11 Gene Knockout Cell Lines empowers researchers and clinicians to advance their studies and foster innovations in therapeutic approaches. Our company prides itself on its commitment to providing high-quality biological products backed by years of experience in genetic engineering and cell line development, ensuring our customers have access to the best tools for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.